|
Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Multiple Sclerosis
|
2017
|
NINDS
|
1R35NS097303-01
|
|
Pathogenesis of Neurological Disability in Primary Diseases of Myelin
|
TRAPP, BRUCE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$871,750
|
Multiple Sclerosis
|
2017
|
NIAID
|
1K22AI125466-01
|
|
CYTOKINES SHAPE GLIAL BIOLOGY DURING REPAIR OF THE ADULT CNS
|
WILLIAMS, JESSICA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$162,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI110113-03
|
|
2D affinity and frequency of antigen specific Tregs
|
EVAVOLD, BRIAN
|
EMORY UNIVERSITY
|
GA
|
$387,900
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI080885-07
|
|
Roles of nucleoporins in RORgammat-dependent immune functions
|
LITTMAN, DAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,750
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI120202-02
|
|
Maternal Regulatory T cell antigen-specificity
|
WAY, SING SING
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$390,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI110822-03
|
|
Regulation of Th17 Functions in Autoimmune CNS Inflammation
|
MCGEACHY, MANDY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$381,220
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI121436-02
|
|
Roles of DDX5 and its associated long non-coding RNAs in RORgt-mediated host immune system functions
|
LITTMAN, DAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$536,329
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI040614-19
|
|
In vivo role of CTLA-4 in Costimulation and Autoimmunity
|
SHARPE, ARLENE
|
HARVARD MEDICAL SCHOOL
|
MA
|
$423,750
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI103867-04
|
|
Structural correlates of T cell receptor signaling
|
GARCIA, KENAN
|
STANFORD UNIVERSITY
|
CA
|
$443,853
|
Multiple Sclerosis
|
2017
|
NEI
|
5R01EY019014-07
|
|
Mechanism of SIRT1 Activator Mediated Neuroprotection of Retinal Ganglion Cells
|
SHINDLER, KENNETH
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$360,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI121147-02
|
|
Balance of Thymic Negative Selection vs. Treg Cell Generation in the Elderly
|
SU, DONG-MING
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$328,500
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI101378-06
|
|
DLL4 Regulation of T Cell Migration in EAE
|
KARPUS, WILLIAM
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$382,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS076410-05
|
8634
|
Transcriptional regulations of effector and regulatory T cells in EAE
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$252,093
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS076410-05
|
8635
|
A transcriptional network analysis of Tr1 cells
|
LITTMAN, DAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$416,064
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS076410-05
|
8639
|
Molecular Analysis of Effector and Regulatory T cell Responses in MS
|
WEINER, HOWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$252,095
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS076410-05
|
8643
|
Expression Profiling Core
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$111,848
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F32NS087899-04
|
|
Regulation of IL7R splicing by DDX39B and its role in Multiple Sclerosis
|
GALARZA MUNOZ, GADDIEL
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
TX
|
$60,990
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS079796-05
|
|
Gamma-Secretase and Myelin: A Paradigm Shift in Brain Disorders
|
YU, GANG
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$347,813
|
Multiple Sclerosis
|
2017
|
NCCIH
|
5K23AT008211-03
|
|
Mindfulness-based Stress Reduction for Multiple Sclerosis: Feasibility, Durability, and Clinical Outcomes
|
SENDERS, ANGELA
|
NATIONAL UNIVERSITY OF NATURAL MEDICINE
|
OR
|
$134,510
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI079056-09
|
|
The roles of Sirt1, a deacetylase, in immune tolerance and autoimmunity
|
FANG, DEYU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$386,250
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS083542-03
|
|
Role of LRP1 in NF-kB mediated neuroinflammation
|
GAULTIER, ALBAN
|
UNIVERSITY OF VIRGINIA
|
VA
|
$392,327
|
Multiple Sclerosis
|
2017
|
NEI
|
5R01EY022936-05
|
|
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica
|
BENNETT, JEFFREY
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$388,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F31NS092371-03
|
|
The Effects of Voluntary Exercise on Oligodendroglia and Myelin in Developing and Cuprizone-Treated Mice.
|
TOMLINSON, LYL
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$25,935
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS096524-02
|
|
Vascular protection via alpha5beta1 integrin inhibition during neuroinflammation
|
MILNER, D
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$230,125
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS096569-02
|
|
Pathogenesis of Theiler's virus-induced demyelinating disease
|
ROOS, RAYMOND
|
UNIVERSITY OF CHICAGO
|
IL
|
$197,500
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI105887-04
|
|
Metabolic checkpoint in TH17 cell differentiation
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$437,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS096363-02
|
|
Mechanisms of sex differences in blood-brain barrier biology
|
KLEIN, ROBYN
|
WASHINGTON UNIVERSITY
|
MO
|
$228,750
|
Multiple Sclerosis
|
2017
|
NIDCD
|
5R01DC013157-04
|
|
Synaptic mechanisms underlying auditory function and dysfunction
|
KIM, JUN HEE
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$315,163
|
Multiple Sclerosis
|
2017
|
NIGMS
|
1SC1GM121198-01
|
|
Method for Large-scale Quantitative Analysis of Myelin in Living Animals
|
LIM, HYUNGSIK
|
HUNTER COLLEGE
|
NY
|
$338,400
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS081141-05
|
|
Stimulating oligodendrocyte progenitor cell differentiation and remyelination
|
TIWARI-WOODRUFF, SEEMA
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
CA
|
$332,500
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R21AI127354-01
|
|
Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple Sclerosis
|
GUERAU-DE-ARELLANO, MIREIA
|
OHIO STATE UNIVERSITY
|
OH
|
$220,875
|
Multiple Sclerosis
|
2017
|
NEI
|
1R01EY027346-01
|
|
Pathogenic B cell and T helper cell interactions in Neuromyelitis Optica
|
AXTELL, ROBERT
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$436,250
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI128074-01
|
|
Restoring Immune Tolerance in a Model of Multiple Sclerosis
|
HOFFMAN, BRAD
|
UNIVERSITY OF FLORIDA
|
FL
|
$381,250
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS095884-02
|
|
Elucidating mechanisms involved in Lamin B1 mediated demyelination
|
PADIATH, QUASAR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$395,197
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI123131-02
|
|
Transplantation of ESC-derived thymic epithelial progenitors expressing autoantigen(s) ameliorating experimental autoimmune encephalomyelitis
|
LAI, LAIJUN
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$395,000
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS093134-02
|
|
Anti-Axl and anti-Mer antibody treatment to reduce the clinical course of EAE
|
SHAFIT-ZAGARDO, BRIDGET
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
NY
|
$208,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F32NS092448-03
|
|
Maintenance and Reorganization of Molecular Domains in Myelinated Axons
|
TAYLOR, ANNA
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$59,166
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R21AI127997-01
|
|
Role of STAT3 in Treg during Autoimmune CNS Inflammation
|
CHANG, SEON HEE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$200,000
|
Multiple Sclerosis
|
2017
|
NINDS
|
1K99NS099469-01
|
|
Uncovering mechanisms of myelin formation and regeneration in the live brain
|
HILL, ROBERT
|
YALE UNIVERSITY
|
CT
|
$90,666
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI114581-03
|
|
Metabolic programming in TH17 cell differentiation
|
WANG, RUONING
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$373,750
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R21AI117440-02
|
|
Regulation of Th17 immune responses by serpinB1
|
REMOLD-O'DONNELL, EILEEN
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$221,250
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI105836-04
|
|
Novel RORgamma antagonists for inflammation and autoimmune disease
|
NEFZI, ADEL
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
FL
|
$584,371
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS081687-05
|
|
Molecular mechanisms of Th17 plasticity in MS
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$382,156
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F31NS096824-02
|
|
Pathogenic consequences of B cell-mediated CD4 T cell activation in a MHCII-dependent model of central nervous system autoimmunity
|
PARKER HARP, CHELSEA
|
WASHINGTON UNIVERSITY
|
MO
|
$30,728
|
Multiple Sclerosis
|
2017
|
NIGMS
|
5R01GM063074-14
|
|
Molecular Organization and Function of Paranodal Axo-Glial Junctions
|
BHAT, MANZOOR
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$331,848
|
Multiple Sclerosis
|
2017
|
NICHD
|
5R01HD087566-02
|
|
Regenerating CNS white matter using induced pluripotent stem cells
|
DENG, WENBIN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$325,775
|
Multiple Sclerosis
|
2017
|
NIEHS
|
1R15ES027650-01
|
|
TCDD-treated B Cells Modulate T Effector and T Regulatory Function in EAE
|
KAPLAN, BARBARA
|
MISSISSIPPI STATE UNIVERSITY
|
MS
|
$436,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F31NS096814-02
|
|
Control of myelinating glial cell development by actr10
|
HERBERT, AMY
|
WASHINGTON UNIVERSITY
|
MO
|
$30,608
|
Multiple Sclerosis
|
2017
|
NIBIB
|
5R01EB013198-08
|
|
Antigen loaded particles for tolerance induction
|
SHEA, LONNIE
|
UNIVERSITY OF MICHIGAN
|
MI
|
$526,590
|
Multiple Sclerosis
|
2017
|
NEI
|
5R01EY023240-05
|
|
Microstructural Characterization of the Optic Nerve in Optic Neuritis
|
SMITH, SETH
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$264,167
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R21AI124676-02
|
|
Dissecting the role of the ATF4 stress response in T cell-mediated inflammation
|
LU, BINFENG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$232,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS057194-09
|
|
Regulation of Autoimmune Encephalomyelitis
|
ZAGHOUANI, HABIB
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$325,504
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI121166-02
|
|
Leukocyte Activation and Migration in Autoimmune Encephalomyelitis
|
CHEN, YOUHAI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$402,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5K23NS096056-02
|
|
Characterizing axonal damage in multiple sclerosis using TractCaliber MRI
|
HUANG, SUSIE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$192,821
|
Multiple Sclerosis
|
2017
|
NINDS
|
5K23NS072366-05
|
|
Grey Matter of Lesions and Neurodegeration in Multiple Sclerosis on 7-Telsa MRI
|
HARRISON, DANIEL
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$180,290
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS091939-02
|
|
Viral-induced axonopathy: mechanisms of damage and repair
|
LANE, THOMAS
|
UNIVERSITY OF UTAH
|
UT
|
$368,775
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS092042-03
|
|
Human neural precursor cell-mediated therapy in a viral model of demyelination
|
LANE, THOMAS
|
UNIVERSITY OF UTAH
|
UT
|
$558,002
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI113007-03
|
|
STAT4 regulation of effector CD4 T cells and CNS inflammation
|
HARRINGTON, LAURIE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$367,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS088367-04
|
|
A Mouse Model to Define Immunovirologic Determinants of Polyomavirus CNS Disease
|
LUKACHER, ARON
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$334,688
|
Multiple Sclerosis
|
2017
|
NIAAA
|
1R21AA024873-01A1
|
|
Regulation of gray matter myelination by adolescent binge ethanol treatment
|
GU, CHEN
|
OHIO STATE UNIVERSITY
|
OH
|
$222,094
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI113903-04
|
|
Functions of Hopx in immune tolerance in a model of Multiple Sclerosis
|
HAWIGER, DANIEL
|
SAINT LOUIS UNIVERSITY
|
MO
|
$376,476
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI113118-03
|
|
UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
|
EDELSON, BRIAN
|
WASHINGTON UNIVERSITY
|
MO
|
$381,250
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS086981-03
|
|
Bringing CLARITY to EAE
|
MACKENZIE-GRAHAM, ALLAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$336,875
|
Multiple Sclerosis
|
2017
|
NIAID
|
2R01AI124386-10A1
|
|
Mechanisms of GM-CSF effect in CNS autoimmune demyelination
|
ROSTAMI, A.M.
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$390,000
|
Multiple Sclerosis
|
2017
|
NEI
|
5R21EY026684-02
|
|
Treatment strategies for autoimmune demyelinating optic neuritis
|
PLAFKER, SCOTT
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$214,375
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS089004-02
|
|
Novel Ultrashort Echo Time Sequences for Brain MRI
|
LARSON, PEDER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$237,750
|
Multiple Sclerosis
|
2017
|
NIDDK
|
5F31DK108540-02
|
|
Intestinal Dysmotility in Multiple Sclerosis
|
SPEAR, ESTELLE
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$28,984
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R21AI128991-01
|
|
IL-17 Isoforms in Organ Specific Autoimmunity
|
GAFFEN, SARAH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$188,994
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F31NS096906-02
|
|
The Mechanisms of Estrogen Receptor Beta Ligand Mediated Neuroprotection
|
KIM, YOUN-JUNG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$35,153
|
Multiple Sclerosis
|
2017
|
NEI
|
5R01EY013574-15
|
|
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies
|
VERKMAN, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$396,250
|
Multiple Sclerosis
|
2017
|
NIDDK
|
5R01DK105550-05
|
|
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
|
RATHMELL, JEFFREY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$377,741
|
Multiple Sclerosis
|
2017
|
NINDS
|
1F31NS098642-01A1
|
|
The role of CHPG in oligodendrocyte regeneration
|
SAITTA, KYLE
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
NJ
|
$34,081
|
Multiple Sclerosis
|
2017
|
NIAID
|
5P01AI108545-03
|
5975
|
Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
|
SHARPE, ARLENE
|
HARVARD MEDICAL SCHOOL
|
MA
|
$467,689
|
Multiple Sclerosis
|
2017
|
NINDS
|
1F31NS097209-01A1
|
|
In vitro brain post-capillary venule model: A platform to investigate leukocyte infiltration for multiple sclerosis therapeutic applications
|
XU, ZINNIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$43,576
|
Multiple Sclerosis
|
2017
|
NINDS
|
1F31NS096857-01A1
|
|
Using Microfluidics to Investigate Mechanisms of Leukocyte Intravascular Crawling
|
BENSON, BRYAN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$37,176
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R13AI129380-01
|
|
2017 Neuroimmune Communication in Health and Disease Gordon Research Conference
|
FABRY, ZSUZSANNA
|
GORDON RESEARCH CONFERENCES
|
RI
|
$4,000
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R13AI129380-01
|
|
2017 Neuroimmune Communication in Health and Disease Gordon Research Conference
|
FABRY, ZSUZSANNA
|
GORDON RESEARCH CONFERENCES
|
RI
|
$5,000
|
Multiple Sclerosis
|
2017
|
NIBIB
|
5R21EB020760-02
|
|
Fast Whole-Brain Direct Myelin Magnetic Resonance Imaging
|
STENGER, VICTOR
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$176,875
|
Multiple Sclerosis
|
2017
|
NINDS
|
5K08NS078555-05
|
|
immunopathogenesis of NMO-IgG and AQP4-specific T cells in neuromyelitis optica
|
LEVY, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$193,023
|
Multiple Sclerosis
|
2017
|
NIAID
|
5UM1AI110557-04
|
|
University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr
|
FOX, DAVID
|
UNIVERSITY OF MICHIGAN
|
MI
|
$77,500
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI104519-05
|
|
Signaling functions of Peli family of E3 ubiquitin ligases
|
SUN, SHAO-CONG
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
TX
|
$421,034
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI129548-01
|
|
Regulation of pathogenic T cells in EAE
|
BETTELLI, ESTELLE
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$428,750
|
Multiple Sclerosis
|
2017
|
NIEHS
|
5R01ES022966-04
|
|
AhR and Regulatory T cells
|
MCKARNS, SUSAN
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$322,905
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS092662-02
|
|
Pathogenesis of Mouse Polyomavirus-associated CNS Demyelination
|
LUKACHER, ARON
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$336,463
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI099216-05
|
|
Autoimmune Encephalomyelitis And Regulatory T Cells
|
CHEN, YOUHAI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$400,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI119135-03
|
|
HuR regulates Th17 cells for promoting autoimmune neuroinflammation
|
YU, SHIGUANG
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$373,205
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI126398-02
|
|
Interferon-beta as an Adjuvant for Tolerogenic Vaccination
|
MANNIE, MARK
|
EAST CAROLINA UNIVERSITY
|
NC
|
$416,673
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS094151-02
|
|
The effects of NF-kB on oligodendrocytes in models of multiple sclerosis
|
LIN, WENSHENG
|
UNIVERSITY OF MINNESOTA
|
MN
|
$332,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS093349-02
|
|
Spatiotemporal Modeling of MRI Brain Lesion Trajectories of Biomarker Discovery
|
SHINOHARA, RUSSELL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$231,013
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS082347-05
|
|
Imaging neurodegeneration in multiple sclerosis
|
CALABRESI, PETER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$354,375
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS095008-02
|
|
Defining the role of vitamin D in multiple sclerosis
|
LOVETT-RACKE, AMY
|
OHIO STATE UNIVERSITY
|
OH
|
$192,500
|
Multiple Sclerosis
|
2017
|
NCCIH
|
5R01AT007452-04
|
|
Mechanisms of human immune modulation by oral N-acetylglucosamine
|
DEMETRIOU, MICHAEL
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$408,738
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS082102-05
|
|
Virus Infection Leads to Autoreactive T Cells Having Multiple TCRs
|
FUJINAMI, ROBERT
|
UNIVERSITY OF UTAH
|
UT
|
$325,938
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS094765-02
|
|
Immune Contribution to Brain Atrophy
|
JOHNSON, AARON
|
MAYO CLINIC ROCHESTER
|
MN
|
$198,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS096148-02
|
|
MicroRNAs as critical regulators of remyelination in Multiple Sclerosis
|
DUTTA, RANJAN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$346,719
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS059560-09
|
5149
|
Validating diffusion MRI biomarkers of inflammation and axon pathologies in EAE
|
SONG, SHENG-KWEI
|
WASHINGTON UNIVERSITY
|
MO
|
$197,619
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS059560-09
|
5150
|
Targeting the BBB to treat CNS inflammation
|
KLEIN, ROBYN
|
WASHINGTON UNIVERSITY
|
MO
|
$283,079
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS059560-09
|
5151
|
BIOMARKERS AND PATHOGENESIS OF MS: FROM MOUSE TO HUMAN
|
CROSS, DOROTHY
|
WASHINGTON UNIVERSITY
|
MO
|
$327,551
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS059560-09
|
5153
|
Animal Models, Histology and Tissue Bank Core
|
KLEIN, ROBYN
|
WASHINGTON UNIVERSITY
|
MO
|
$137,398
|
Multiple Sclerosis
|
2017
|
NINDS
|
5P01NS059560-09
|
5154
|
Image Data Acquisition, Analysis, and Modeling Core
|
SONG, SHENG-KWEI
|
WASHINGTON UNIVERSITY
|
MO
|
$204,400
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI121567-02
|
|
Immune Dysregulation During Multiple Sclerosis Relapse
|
KARANDIKAR, NITIN
|
UNIVERSITY OF IOWA
|
IA
|
$732,451
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R37AI107494-05
|
|
Mechanisms by which CD8 T cells shape CNS autoimmunity initiated by CD4 T cells
|
GOVERMAN, JOAN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$481,876
|
Multiple Sclerosis
|
2017
|
NIAID
|
5P01AI073748-08
|
8634
|
Tim-3 regulation of CNS autoimmune responses
|
HAFLER, DAVID
|
YALE UNIVERSITY
|
CT
|
$423,630
|
Multiple Sclerosis
|
2017
|
NINDS
|
5U01NS082329-05
|
|
Ibudilast Phase II trial in progressive MS
|
FOX, ROBERT
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$284,857
|
Multiple Sclerosis
|
2017
|
NINR
|
5R01NR014362-05
|
|
A Multi-Site Trial of a Cognitive Rehabilitation Intervention for Persons with MS
|
STUIFBERGEN, ALEXA
|
UNIVERSITY OF TEXAS, AUSTIN
|
TX
|
$412,714
|
Multiple Sclerosis
|
2017
|
NIEHS
|
5R01ES025530-02
|
|
Role of AHR in Dendritic Cells in the Control of the CNS Autoimmunity
|
QUINTANA, FRANCISCO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$371,475
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS097313-02
|
|
Targeting toll like receptor 4 (TLR4) and TLR2 to resolve EAE-associated paralysis, pain and cognitive deficits: efficacy of a clinically-relevant blood brain barrier permeable TLR4/TLR2 antagonist
|
WATKINS, LINDA
|
UNIVERSITY OF COLORADO
|
CO
|
$336,875
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS095007-02
|
|
Gene-Environment Interactions in CNS Autoimmune Disease
|
TEUSCHER, CORY
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$194,843
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS100924-01
|
|
Deletion of Mitochondrial Anchoring Protects Late Phase Multiple Sclerosis
|
CHIU, SHING
|
UNIVERSITY OF WISCONSIN-MADISON
|
WI
|
$334,688
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI130547-01
|
|
Altered CD4+ T cell function in relation to the AHI1 MS locus
|
ELYAMAN, WASSIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$432,647
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS083678-05
|
|
ROLE OF B CELL ANTIGEN PRESENTATION IN AUTOIMMUNE ENCEPHALOMYELITIS
|
WU, GREGORY
|
WASHINGTON UNIVERSITY
|
MO
|
$332,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS092650-03
|
|
UTE Magnetic Resonance Imaging: New Biomarkers for Multiple Sclerosis
|
DU, JIANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$364,303
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS081237-05
|
|
Modulating B and T cell functions in EAE through gamma secretase and Notch
|
EAGAR, TODD
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
TX
|
$275,625
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS078041-05
|
|
Modulation of oligodendrocyte development by voltage-operated calcium channels.
|
PAEZ, PABLO
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$348,906
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS085103-04
|
|
Kruppel-like factor-6 signaling in myelin formation and repair
|
JOHN, GARETH
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$370,781
|
Multiple Sclerosis
|
2017
|
NINDS
|
5K23NS087151-03
|
|
The effect of vitamin D3 on markers of oxidative stress in boys with X-linked ALD
|
VAN HAREN, KEITH
|
STANFORD UNIVERSITY
|
CA
|
$185,835
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS090383-04
|
|
Role of Endothelin-1 in remyelination
|
GALLO, VITTORIO
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$376,250
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS080890-05
|
|
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
|
OFFNER, HALINA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$275,625
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI108634-04
|
|
The roles of Synoviolin in immune tolerance and autoimmunity
|
FANG, DEYU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$379,464
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS094181-03
|
|
Transcription mechanism of Myrf for central nervous system myelination
|
PARK, YUNGKI
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$413,684
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS086299-05
|
|
Regulation of B cells in the CNS
|
BERGMANN, CORNELIA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$346,719
|
Multiple Sclerosis
|
2017
|
NICHD
|
5R01HD080601-04
|
|
Chemical and Genetic Screens for Modulators of Nervous System Development
|
MONK, KELLY
|
WASHINGTON UNIVERSITY
|
MO
|
$315,400
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS088729-04
|
|
The Role of GM-CSF in the Pathogenesis of Multiple Sclerosis
|
ROSTAMI, A.M.
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$341,250
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R21AI124116-02
|
|
Modulation neuroinflammation through interference of cooperative microRNA-RNA-binding protein interactions
|
BENDER, JEFFREY
|
YALE UNIVERSITY
|
CT
|
$167,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS082257-05
|
|
Investigating the mechanism of TNFalpha mediated cell death in oligodendrocytes
|
YUAN, JUNYING
|
HARVARD MEDICAL SCHOOL
|
MA
|
$370,781
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS098200-02
|
|
Investigation of Novel Roles For IRF7 in EAE
|
IRANI, DAVID
|
UNIVERSITY OF MICHIGAN
|
MI
|
$193,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F30NS095498-02
|
|
Oligodendrocyte-Specific Regulation of Mitochondrial Function
|
MINCHENBERG, SCOTT
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$43,576
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI090901-12
|
|
Nedd4 in T Helper Cell Development and Autoimmunity
|
ZHANG, JIAN
|
OHIO STATE UNIVERSITY
|
OH
|
$514,990
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI121405-02
|
|
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity
|
GUERAU-DE-ARELLANO, MIREIA
|
OHIO STATE UNIVERSITY
|
OH
|
$438,928
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI121945-02
|
|
Cellular and Molecular Mechanisms of Regulatory T Cells in EAE
|
CAHALAN, MICHAEL
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
CA
|
$498,868
|
Multiple Sclerosis
|
2017
|
NEI
|
5R01EY024655-04
|
|
3D segmentation and registration of macular SD-OCT for application in MS
|
PRINCE, JERRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$396,584
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS091183-03
|
|
IL-10-dependent regulation of viral-induced demyelination
|
BERGMANN, CORNELIA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$379,814
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R21AI122100-02
|
|
Somatic Mutation in the Etiology of Multiple Sclerosis
|
SCHEUERMANN, RICHARD
|
J. CRAIG VENTER INSTITUTE, INC.
|
CA
|
$195,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI125247-01A1
|
|
The role of IL-27/Lag3 axis in regulating Foxp3+ regulatory T cell function
|
MIN, BOOKI
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$396,250
|
Multiple Sclerosis
|
2017
|
NHLBI
|
5R01HL095722-08
|
|
Engineered Induction of a Stem Cell Homing Response
|
KARP, JEFFREY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$443,750
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI106026-12
|
|
The role of IL-27 in iv tolerance in EAE
|
ROSTAMI, A.M.
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$387,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R37NS042925-15
|
|
Histone Deacetylation in Oligodendrocyte Differentiation
|
CASACCIA, PATRIZIA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$629,289
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS092835-03
|
|
Disease relevance of CD20 expression on T cells in multiple sclerosis patients
|
HAUSER, STEPHEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$492,230
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS088437-04
|
|
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy
|
LI, CHENGLONG
|
UNIVERSITY OF FLORIDA
|
FL
|
$342,568
|
Multiple Sclerosis
|
2017
|
NIAID
|
2U01AI101984-06
|
|
Tissue Cytokine Sequestration and Immune Regulation in Autoimmunity
|
BOLLYKY, PAUL
|
STANFORD UNIVERSITY
|
CA
|
$632,042
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F31NS093935-03
|
|
The Role of ADAM10 in Central Nervous System Myelination and Remyelination
|
KLINGENER, MICHAEL
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$43,576
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS097551-01A1
|
|
Vasculature provides the substrate for oligodendrocyte progenitor migration in development and disease
|
FANCY, STEPHEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$346,719
|
Multiple Sclerosis
|
2017
|
NICHD
|
5DP1HD087988-03
|
|
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
|
WU, HAO
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$442,500
|
Multiple Sclerosis
|
2017
|
RMAP
|
5DP1HD087988-03
|
|
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug Discovery
|
WU, HAO
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$442,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS064599-09
|
|
The MKP-1/p38 axis: coordinating innate and adaptive immunity
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$382,813
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS097596-01A1
|
|
Interactions Between Host Genetics and the Gut Microbiome in CNS Autoimmunity
|
KREMENTSOV, DIMITRY
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$339,883
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI123308-01A1
|
|
A map of sphingosine 1-phosphate distribution
|
SCHWAB, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
2R01NS073425-06A1
|
|
Homeostatic regulation of NG2 cell dynamics
|
NISHIYAMA, AKIKO
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$338,979
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS093357-03
|
|
Human iPSC and glial chimeric modeling of Pelizaeus-Merzbacher Disease
|
TESAR, PAUL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$371,793
|
Multiple Sclerosis
|
2017
|
NICHD
|
5R01HD082176-02
|
|
Protection Against Cognitive Decline in MS: Longitudinal Investigation of Reserve
|
SUMOWSKI, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$615,081
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS098400-02
|
|
Development of Peptide Targeting Technology for Demyelinating Lesions
|
RANSCHT, BARBARA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
|
CA
|
$243,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS094499-02
|
|
Axonal myelination of interneurons in cortex: functional significance and plasticity
|
MADISON, VERNON
|
STANFORD UNIVERSITY
|
CA
|
$346,018
|
Multiple Sclerosis
|
2017
|
NICHD
|
5F30HD084167-03
|
|
Identifying molecular and cellular deficits in a human model of myelin disease
|
NEVIN, ZACHARY
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$41,029
|
Multiple Sclerosis
|
2017
|
NINDS
|
2R01NS036592-19
|
|
Role of microglia in MHV-induced demyelination
|
PERLMAN, STANLEY
|
UNIVERSITY OF IOWA
|
IA
|
$327,795
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R03NS098123-01A1
|
|
The contribution of cyclophilin A to immune-mediated inflammatory disorders of the central nervous system
|
OH, UNSONG
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$76,250
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI123947-01A1
|
|
AhR ligands in epigenetic dysregulation of T cells
|
NAGARKATTI, MITZI
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$333,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS096212-02
|
|
Genetic and Phenotypic Analysis of Multiple Sclerosis in Hispanics
|
MCCAULEY, JACOB
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$620,060
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS088137-04
|
|
Mechanism of regulation of CNS inflammation by microglia
|
BUTOVSKY, OLEG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$341,258
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R44AI112512-03
|
|
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immune related Diseases
|
CHANDRARATNA, ROSH
|
IO THERAPEUTICS, INC.
|
CA
|
$1,000,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI106923-04
|
|
The Role of microRNAs in autoimmune disease
|
JEKER, LUKAS
|
UNIVERSITY HOSPITAL BASEL
|
SWITZE
|
$257,495
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS037766-18
|
|
Cytokines in Glial Cells and EAE Brain
|
SINGH, INDERJIT
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$327,031
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS094522-03
|
|
Molecular mechanisms of the protective function of oligodendroglial TNFR2: a new therapeutic target in neuro-immune disease
|
BRAMBILLA, ROBERTA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$335,781
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS026799-27
|
|
Gene linkage study of multiple sclerosis sibling pairs
|
HAUSER, STEPHEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$424,978
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS094559-02
|
|
The Wnt-independent role of TCF7l2 in CNS myelin formation and repair
|
GUO, FUZHENG
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
CA
|
$343,438
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F31NS096885-02
|
|
Establishing the Causal Role of Low Vitamin D in Multiple Sclerosis
|
RHEAD, BROOKE
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$40,132
|
Multiple Sclerosis
|
2017
|
RMAP
|
5UH3TR000918-05
|
|
Exosome RNA-Therapeutics to Promote CNS Myelination
|
KRAIG, RICHARD
|
UNIVERSITY OF CHICAGO
|
IL
|
$323,545
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R21AI124735-02
|
|
Role of Dock8 in EAE
|
OUKKA, MOHAMED
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$241,125
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS030800-21
|
|
development of oligodendrocytes in the spinal cord
|
MILLER, ROBERT
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$346,719
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS057563-09
|
|
Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation
|
BENVENISTE, ETTY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$321,563
|
Multiple Sclerosis
|
2017
|
NINDS
|
1F31NS098575-01A1
|
|
High fat diet impacts disease course in preclinical models of MS through DNA methylation changes in monocytes
|
CASTRO, KAMILAH
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$40,776
|
Multiple Sclerosis
|
2017
|
NIBIB
|
5R21EB021397-02
|
|
Development and validation of a multimodal MRI/near-infrared spectroscopysystem to study brain oxidative metabolism in mouse models of neurologicaldisease
|
DUNN, JEFFREY
|
UNIVERSITY OF CALGARY
|
CANADA
|
$147,423
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS078322-05
|
|
Cortical mechanisms of disease progression in early multiple sclerosis
|
MAINERO, CATERINA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$380,625
|
Multiple Sclerosis
|
2017
|
NINDS
|
5F32NS098647-02
|
|
The role of Endothelin-1 in oligodendrocyte development and regeneration
|
ADAMS, KATRINA
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$61,866
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS041249-17
|
|
Chemokines and Viral-Induced Neurologic Disease
|
LANE, THOMAS
|
UNIVERSITY OF UTAH
|
UT
|
$325,938
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS099068-01A1
|
|
Binding of Epstein Barr Virus EBNA2 unifies multiple sclerosis genetic mechanisms
|
WEIRAUCH, MATTHEW
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$346,991
|
Multiple Sclerosis
|
2017
|
NIEHS
|
3R01ES022966-03S2
|
|
AhR and Regulatory T cells
|
MCKARNS, SUSAN
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$81,815
|
Multiple Sclerosis
|
2017
|
NIAID
|
5P01AI045757-19
|
6983
|
Molecular Characterization of Myelin-Specific T cells from MS Patients
|
WUCHERPFENNIG, KAI
|
DANA-FARBER CANCER INST
|
MA
|
$392,781
|
Multiple Sclerosis
|
2017
|
NIAID
|
5P01AI045757-19
|
6984
|
T:B Collaboration and Induction of Autoimmune Tissue Inflammation
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$354,185
|
Multiple Sclerosis
|
2017
|
NIAID
|
5P01AI045757-19
|
6985
|
Regulation of T cell immunity by stromal cells in autoimmune tissue inflammation
|
REGEV, AVIV
|
DANA-FARBER CANCER INST
|
MA
|
$344,130
|
Multiple Sclerosis
|
2017
|
NIAID
|
5P01AI045757-19
|
6986
|
Novel Technologies for Investigation of Self-reactive T cells in MS and Relevant
|
LOVE, JOHN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$172,313
|
Multiple Sclerosis
|
2017
|
NINR
|
1F31NR017121-01
|
|
Specific and Pervasive Symptoms in Adults with Multiple Sclerosis Using the MURDOCK-MS Dataset: A Secondary Analysis
|
WAINWRIGHT, KRISTIN
|
DUKE UNIVERSITY
|
NC
|
$35,013
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI127853-01A1
|
|
MICRORNA CONTROL OF INFLAMMATORY AND REGULATORY T CELLS IN CENTRAL NERVOUS SYSTEM AUTOIMMUNITY
|
GOPAL, MURUGAIYAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$439,410
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS088155-04
|
|
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
|
BARANZINI, SERGIO
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$407,247
|
Multiple Sclerosis
|
2017
|
NICHD
|
5R21HD086368-02
|
|
Neuroprotective role of vitamin D during childhood
|
LOVETT-RACKE, AMY
|
OHIO STATE UNIVERSITY
|
OH
|
$192,500
|
Multiple Sclerosis
|
2017
|
NIDA
|
1R43DA043947-01
|
|
High Resolution Microbiome Profiling System
|
DRISCOLL, MARK
|
SHORELINE BIOME, LLC
|
CT
|
$225,000
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS045883-10
|
|
Mechanisms in CNS myelination: Role of PD-lalpha/ATX
|
FUSS, BABETTE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$369,408
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS088040-04
|
|
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
|
FIEREMANS, ELS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$370,781
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS087226-04
|
|
Gut Microbiota in Patients with Multiple Sclerosis
|
WEINER, HOWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$388,281
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI126880-01A1
|
|
Regulation of CNS Autoimmunity
|
QUINTANA, FRANCISCO
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$412,750
|
Multiple Sclerosis
|
2017
|
NIAID
|
5P01AI056299-14
|
5194
|
T Cell costimulation: Induction and Regulation of Autoimmunity
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$535,783
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS062703-08
|
|
Reactive astrocytes control leukocyte and humoral trafficking into the CNS
|
JOHN, GARETH
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$370,781
|
Multiple Sclerosis
|
2017
|
RMAP
|
5UH3TR000890-05
|
|
Circulating MicroRNAs as Disease Biomarkers in Multiple Sclerosis
|
WEINER, HOWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$325,769
|
Multiple Sclerosis
|
2017
|
NIAID
|
5U19NS095774-03
|
7006
|
BioRepository Core
|
OKSENBERG, JORGE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$27,672
|
Multiple Sclerosis
|
2017
|
NINDS
|
5U19NS095774-03
|
7006
|
BioRepository Core
|
OKSENBERG, JORGE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$53,859
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R35NS097976-02
|
|
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
|
AKASSOGLOU, KATERINA
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$1,368,800
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS095280-03
|
|
Drug-mediated enhancement of myelination
|
TESAR, PAUL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$374,888
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS096413-02
|
|
Novel gene editing strategy for eliminating human neurotropic JCV in glial cells
|
WOLLEBO, HASSEN
|
TEMPLE UNIV OF THE COMMONWEALTH
|
PA
|
$195,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI122220-02
|
|
Genomics of NFκB-mediated gene regulation in multiple sclerosis
|
COTSAPAS, CHRIS
|
YALE UNIVERSITY
|
CT
|
$728,582
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS095889-02
|
|
Functional Screening of GPCR Small Molecule Libraries for Remyelination Therapies
|
CHAN, JONAH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$346,719
|
Multiple Sclerosis
|
2017
|
NINDS
|
5K01NS097519-02
|
|
The impact of hedgehog signaling during neuroinflammation
|
ALVAREZ, JORGE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$229,360
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS096748-02
|
|
Parental imprinting of the X chromosome: effects on neurodegeneration
|
VOSKUHL, RHONDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$379,450
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS030843-25
|
|
T cell response to myelin proteolipid protein
|
KUCHROO, VIJAY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$346,829
|
Multiple Sclerosis
|
2017
|
NEI
|
5R01EY025687-03
|
|
Mechanisms of activity-dependent myelination in the visual system
|
DESILVA, TARA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$396,250
|
Multiple Sclerosis
|
2017
|
NIAID
|
5R01AI101982-05
|
|
Modulation of Inflammatory Responses by Helminth Glycans
|
CUMMINGS, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$495,849
|
Multiple Sclerosis
|
2017
|
NIAID
|
2R42AI122574-02
|
|
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects
|
VANDENBARK, ARTHUR
|
VIROGENOMICS BIODEVELOPMENT, INC.
|
OR
|
$702,706
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS036647-15
|
|
The Role of Neurotrophins in Oligodendrocyte Function
|
DREYFUS, CHERYL
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
NJ
|
$347,813
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS094164-03
|
|
Adhesion G protein-coupled receptors in CNS development and regeneration
|
PIAO, XIANHUA
|
BOSTON CHILDREN'S HOSPITAL
|
MA
|
$387,188
|
Multiple Sclerosis
|
2017
|
RMAP
|
1DP2CA228044-01
|
|
Chemical biology of innate immunity for treating cancer and autoimmunity
|
LI, LINGYIN
|
STANFORD UNIVERSITY
|
CA
|
$2,355,000
|
Multiple Sclerosis
|
2017
|
NCCIH
|
5P01AT003961-09
|
8452
|
Epigenetic pathways in resveratrol-induced amelioration of neuroinflammation
|
NAGARKATTI, PRAKASH
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$354,717
|
Multiple Sclerosis
|
2017
|
OD
|
1R01NS102163-01
|
|
Nef and neuroAIDS: role of cholesterol metabolism impairment and inflammation
|
BUKRINSKY, MICHAEL
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$200,000
|
Multiple Sclerosis
|
2017
|
NICHD
|
5K23HD086154-02
|
|
An Internet-delivered Cognitive Behavioral Intervention for Sleep Disturbance in Multiple Sclerosis
|
HUGHES, ABBEY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$126,531
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS096443-02
|
|
Using High Throughput Approach to Identify/Characterize Functional Variants on MS
|
LI, GANG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$228,670
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS102153-01
|
|
MHC variation at high resolution in multiple sclerosis
|
OKSENBERG, JORGE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$667,694
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS072427-09
|
|
Molecular Mechanisms of Oligodendrocyte Differentiation and Myelination
|
LU, QING
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$466,702
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS102156-01
|
|
MR metabolic Imaging of Multiple Sclerosis
|
CHAUMEIL, MYRIAM
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$346,719
|
Multiple Sclerosis
|
2017
|
NIAID
|
2P01AI039671-20A1
|
5575
|
Project 3: Integrative approach tounderstanding the mechanism ofcostimulation
|
SHARPE, ARLENE
|
YALE UNIVERSITY
|
CT
|
$813,158
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS096983-02
|
|
Molecular regulation of myelin development and repair by Ick kinase
|
QIU, MENGSHENG
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$192,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R01NS098023-02
|
|
Integrating EHR and Genomics to Predict Multiple Sclerosis Drug Response
|
XIA, ZONGQI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$344,715
|
Multiple Sclerosis
|
2017
|
NINDS
|
5R21NS098169-02
|
|
Cholesterol Biomarkers and Oxysterols in Multiple Sclerosis Progression
|
RAMANATHAN, MURALI
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$199,375
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS102267-01
|
|
Detection, characterization and treatment of chronic microglial inflammation in established MS lesions
|
PITT, DAVID
|
YALE UNIVERSITY
|
CT
|
$561,217
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS102633-01
|
|
Intermittent Fasting-induced Gut Microbiome Modulation of CNS Autoimmunity
|
ZHOU, YANJIAO
|
JACKSON LABORATORY
|
ME
|
$392,985
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI132774-01
|
|
Mechanisms of IL-6 mediated T cell pathogenesis in autoimmunity
|
BUCKNER, JANE
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
WA
|
$841,539
|
Multiple Sclerosis
|
2017
|
NIGMS
|
1R01GM124494-01
|
|
Post-translational modifications in RORgt-dependent immune cell functions
|
HUANG, WENDY JIA MEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$385,222
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R21NS102678-01
|
|
Characterizing the radial component of CNS myelin
|
GOW, ALEXANDER
|
WAYNE STATE UNIVERSITY
|
MI
|
$231,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R21AI132997-01
|
|
Identification of a novel resistance gene for demyelinating disease
|
BLANKENHORN, ELIZABETH
|
DREXEL UNIVERSITY
|
PA
|
$234,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R21NS102762-01
|
|
Improving in vitro generation of human oligodendrocyte lineage cells by mechanical stimulation
|
VAN VLIET, KRYSTYN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$182,117
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R21AI133372-01
|
|
Injectable Biomaterial Scaffold for Inducing Antigen-Specific Tolerance
|
CHENG, HAO
|
DREXEL UNIVERSITY
|
PA
|
$234,750
|
Multiple Sclerosis
|
2017
|
NINDS
|
2R01NS060910-09A1
|
|
Statistical Methods for Multilevel Multivariate Functional Studies
|
CRAINICEANU, CIPRIAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$659,178
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS099527-01A1
|
|
Examining the role of brain sodium content in multiplesclerosis using MRI
|
INGLESE, MATILDE
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$590,104
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS099855-01A1
|
|
Regulation of CNS leukocyte extravasation
|
PACHTER, JOEL
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$369,267
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS099334-01A1
|
|
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation
|
MILLER, STEPHEN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$440,219
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS099304-01A1
|
|
PERK Dependent Mechanisms of Neuroinflammation
|
MEARES, GORDON
|
WEST VIRGINIA UNIVERSITY
|
WV
|
$328,125
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS099431-01A1
|
|
Imaging retinal leukocyte-endothelial interaction as a diagnostic marker for multiple sclerosis
|
ALT, CLEMENS
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$416,872
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI128292-01A1
|
|
Distinct mast cell responses in male and female SJL mice underlie sex dimorphic EAE susceptibility
|
BROWN, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$504,341
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R01AI133623-01
|
|
Tolerogenic dual microparticle system for treatment of multiple sclerosis
|
KESELOWSKY, BENJAMIN
|
UNIVERSITY OF FLORIDA
|
FL
|
$520,957
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS099594-01A1
|
|
Ursolic acid: a novel oral therapy for chronic stage of MS/EAE by both immunomodulation and neural repair
|
ZHANG, GUANG-XIAN
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$341,250
|
Multiple Sclerosis
|
2017
|
NINDS
|
3R01NS094181-02S1
|
|
Transcription mechanism of Myrf for central nervous system myelination
|
PARK, YUNGKI
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$33,940
|
Multiple Sclerosis
|
2017
|
NINDS
|
3R01NS091183-02S1
|
|
IL-10-dependent regulation of viral-induced demyelination
|
BERGMANN, CORNELIA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
OH
|
$25,582
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R21AI130585-01A1
|
|
Association between altered gut microbiota and the pathogenesis of Multiple Sclerosis
|
ITO, KOUICHI
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
NJ
|
$229,650
|
Multiple Sclerosis
|
2017
|
NINDS
|
2R01NS075243-07
|
|
Chromatin remodeling control of myelination and remyelination
|
LU, QING
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$446,256
|
Multiple Sclerosis
|
2017
|
NINDS
|
2R01NS071518-06
|
|
2D kinetics of antigen recognition in the CNS
|
EVAVOLD, BRIAN
|
UNIVERSITY OF UTAH
|
UT
|
$331,588
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R21NS103215-01
|
|
The mechanism of action of Granulocyte Macrophage-Colony Stimulating Factor in an animal model of Multiple Sclerosis
|
SEGAL, BENJAMIN
|
UNIVERSITY OF MICHIGAN
|
MI
|
$232,500
|
Multiple Sclerosis
|
2017
|
NINDS
|
1F31NS103327-01
|
|
Targeting metabolic vulnerabilities of immune cells to treat CNS demyelination
|
SEKI, SCOTT
|
UNIVERSITY OF VIRGINIA
|
VA
|
$30,888
|
Multiple Sclerosis
|
2017
|
NICHD
|
1R13HD093140-01
|
|
7th International Symposium on Gait and Balance in Multiple Sclerosis
|
CAMERON, MICHELLE
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
OR
|
$6,000
|
Multiple Sclerosis
|
2017
|
NINDS
|
1F32NS101788-01A1
|
|
Glutamate-Sensitive, Quantitative MRI in MS: Application to Cognitive Impairment
|
O'GRADY, KRISTIN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
TN
|
$56,694
|
Multiple Sclerosis
|
2017
|
NIAID
|
2R44AI124766-02A1
|
|
Long non-coding RNA signatures to classify multiple sclerosis
|
SPURLOCK, CHARLES
|
IQUITY LABS, INC
|
TN
|
$504,933
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R43AI134550-01
|
|
A Novel Tolerance-inducing Probiotic Platform
|
FANGER, NEIL
|
VIRTICI, LLC
|
WA
|
$300,000
|
Multiple Sclerosis
|
2017
|
NIAID
|
1R41AI129571-01A1
|
|
Screening for the autoimmune component of multiple sclerosis
|
WAGNER, DAVID
|
OP-T-MUNE, INC.
|
CO
|
$299,002
|
Multiple Sclerosis
|
2017
|
NINDS
|
1R01NS103988-01
|
|
PET SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1PR1) RADIOTRACERS FOR MULTIPLE SCLEROSIS
|
TU, ZHUDE
|
WASHINGTON UNIVERSITY
|
MO
|
$478,679
|
Multiple Sclerosis
|
2017
|
NIAID
|
272201200010C-15-0-4
|
|
IEDB for Multiple sclerosis, Rheumatoid Arthritis, Lupus, and Type 1 Diabetes
|
SETTE, ALESSANDRO
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$663,880
|
|